Sanofi, BEYFORTUS
As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...
With the peak flu season often occurring during December and January and even into February, Dr. Sharon Nachman, Chief of the ...
Zacks.com on MSN1d
Sanofi Stock Up Almost 23% in 3 Months: Buy, Sell or Hold?Sanofi’s SNY stock has gained 22.7% in the past three months compared with an increase of 2.9% for the industry. The stock ...
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...
As health officials urge Americans to vaccinate themselves against the highly transmissible virus, a survey finds that fewer than half of respondents plan to take the jab. Separately, after last ...
RSV, and flu viruses, the Dubois County Health Department (DCHD) is now offering all three vaccines on a daily basis. Covid-19- CDC recommends everyone 6 months and older get an updated COVID-19 ...
With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.
The 2024 State Scorecard on Women's Health and Reproductive Care was conducted by the Commonwealth Fund, a nonpartisan foundation that promotes a high-performing health care system. (Barbor, 9/16) CBS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback